Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 73, 2018 - Issue 2
519
Views
19
CrossRef citations to date
0
Altmetric
Original Paper

Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab

ORCID Icon, , , , , , ORCID Icon, ORCID Icon, , , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vittorio Fusco, Maura Rossi, Iolanda De Martino, Manuela Alessio, Antonella Fasciolo & Gianmauro Numico. (2018) Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questions. Acta Clinica Belgica 73:2, pages 163-164.
Read now

Articles from other publishers (18)

Zineb Assili, Gilles Dolivet, Julia Salleron, Claire Griffaton-Tallandier, Claire Egloff-Juras & Bérengère Phulpin. (2021) A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva®) Related Osteonecrosis of the Jaw: A Retrospective Study. Journal of Clinical Medicine 10:11, pages 2390.
Crossref
Akanksha Srivastava, Graciela M. Nogueras Gonzalez, Yimin Geng, Alexander M. Won, Maria E. Cabanillas, Aung Naing, Jeffrey N. Myers, Yisheng Li & Mark S. Chambers. (2020) Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis. Supportive Care in Cancer 29:5, pages 2305-2317.
Crossref
Johannes Laimer, Martin Hechenberger, Daniela Müller, Benjamin Walch, Andreas Kolk, Dagmar Schnabl, Michael Schomaker & Emanuel Bruckmoser. (2021) Dental pathologies in tumor patients with bone metastases or multiple myeloma scheduled for antiresorptive therapy. Future Oncology.
Crossref
Francesco Pavese & Silvia Rotondaro. (2021) Use of Radium223 in metastatic prostate cancer patient in treatment with denosumab: a potential trigger for Osteonecrosis of the jaw? A case report.. Qeios.
Crossref
Kazumitsu Aoki, Satoru Matsunaga, Shinichirou Ito, Takahiko Shibahara, Takeshi Nomura, Hideo Matsuzaki, Shinichi Abe & Akira Yamaguchi. (2021) Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis. Journal of Bone and Mineral Metabolism.
Crossref
Marcelo Vieira da Costa Almeida, Antonio C. Moura, Lúcia Santos, Luciana Gominho, Ully Dias Nascimento Távora Cavalcanti & Kaline Romeiro. (2021) Photodynamic Therapy as an adjunct in the Treatment of Medication-Related Osteonecrosis of the Jaw: A Case Report. Journal of Lasers in Medical Sciences 12:1, pages e12-e12.
Crossref
Maura Rossi, Alessio Gambino, Marco Cabras, Manuela Alessio & Vittorio Fusco. (2021) Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points. Supportive Care in Cancer.
Crossref
Ling‐Ying Wei, Sang‐Heng Kok, Yen‐Ching Lee, Wei‐Yih Chiu, Jai‐Jen Wang, Shih‐Jung Cheng, Hao‐Hueng Chang & Jang‐Jaer Lee. (2020) Prognosis of medication‐related osteonecrosis of the jaws in metastatic prostate cancer patients. Oral Diseases.
Crossref
Louise Dunphy, Giovanni Salzano, Barbara Gerber & Jennifer Graystone. (2020) Republished: Medication-related osteonecrosis (MRONJ) of the mandible and maxilla. Drug and Therapeutics Bulletin 58:11, pages 172-175.
Crossref
Jan-Dirk Raguse, Andrej Trampuz, Marcelo Sanchez Boehm, Susanne Nahles, Benedicta Beck-Broichsitter, Max Heiland & Norbert Neckel. (2020) Replacing one evil with another: Is the fibula really a dispensable spare part available for transfer in patients with medication-related osteonecrosis of the jaws?. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 129:6, pages e257-e263.
Crossref
Louise Dunphy, Giovanni Salzano, Barbara Gerber & Jennifer Graystone. (2020) Medication-related osteonecrosis (MRONJ) of the mandible and maxilla. BMJ Case Reports 13:1, pages e224455.
Crossref
Noam Yarom, Charles L. Shapiro, Douglas E. Peterson, Catherine H. Van Poznak, Kari Bohlke, Salvatore L. Ruggiero, Cesar A. Migliorati, Aliya Khan, Archie Morrison, Holly Anderson, Barbara A. Murphy, Devena Alston-Johnson, Rui Amaral Mendes, Beth Michelle Beadle, Siri Beier Jensen & Deborah P. Saunders. (2019) Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline. Journal of Clinical Oncology 37:25, pages 2270-2290.
Crossref
Cesar A Migliorati, Michael T Brennan & Douglas E Peterson. (2019) Medication-Related Osteonecrosis of the Jaws. JNCI Monographs 2019:53.
Crossref
Valeria Dionisi, Chiara Bellarosa, Raffaele Cardano, Elisa Lodi Rizzini, Pietro Ghedini, Alessio Giuseppe Morganti, Stefano Fanti & Fabio Monari. (2019) Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases. Clinical Genitourinary Cancer 17:3, pages e612-e617.
Crossref
Aline Guillot, Charlotte Joly, Philippe Barthélémy, Emeline Meriaux, Sylvie Negrier, Damien Pouessel, Christine Chevreau, Hakim Mahammedi, Nadine Houede, Guilhem Roubaud, Gwenaelle Gravis, Sophie Tartas, Laurence Albiges, Cécile Vassal, Mathieu Oriol, Fabien Tinquaut, Sophie Espenel, Wafa Bouleftour, Stéphane Culine & Karim Fizazi. (2019) Denosumab Toxicity When Combined With Anti-angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study. Clinical Genitourinary Cancer 17:1, pages e38-e43.
Crossref
Yan-Li Yang, Zi-Jian Xiang, Jing-Hua Yang, Wen-Jie Wang & Ruo-Lan Xiang. (2019) The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology 11, pages 175883591985523.
Crossref
Vittorio Fusco, Giuseppina Campisi, Paul de Boissieu, Federico Monaco, Anna Baraldi, Gianmauro Numico & Alberto Bedogni. (2018) Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. A Commentary of the Pivotal Trial by Raje et al. Published on Lancet Oncology. Dentistry Journal 6:3, pages 42.
Crossref
Haidi Bi, Xing Chen, Song Gao, Xiaolong Yu, Jun Xiao, Bin Zhang, Xuqiang Liu & Min Dai. (2017) Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review. Frontiers in Medicine 4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.